Effect of age on efficacy and safety of vorapaxar in patients with non–ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial
Titel:
Effect of age on efficacy and safety of vorapaxar in patients with non–ST-segment elevation acute coronary syndrome: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial
Auteur:
Armaganijan, Luciana V. Alexander, Karen P. Huang, Zhen Tricoci, Pierluigi Held, Claes Van de Werf, Frans Armstrong, Paul W. Aylward, Philip E. White, Harvey D. Moliterno, David J. Wallentin, Lars Chen, Edmond Harrington, Robert A. Strony, John Mahaffey, Kenneth W. Lopes, Renato D.